Efication Of Zinc Supplementation On Differences Of Weight And Height In School Children Post Infected Soil Transmitted Helminth

The prevalence of STH in Indonesia in general is still very high at 60%, especially in the underprivileged population who have a high risk of contracting this disease. STH infection showed an association with zinc concentration. Factors inuencing child growth differ between populations and may depend on prevalences of STH species and zinc deciency. This study was a randomized, non-disguise clinical trial conducted to assess zinc effectiveness on differences of weight and height of children after infection with the Soil Transmitted Helminth (STH) in February-May 2017. All data is recorded in the status of the study, collected and then processed using SPSS 16.0 for Windows computer software. Of the 200 students, 70 met the inclusion criteria and 39 students were willing to measure their weight and height. Based on research using paired T test found signicant differences in mean body weight and height at the beginning and end of the study in each group of zinc supplementation and without zinc supplementation. Based on this study there were signicant differences in mean weight and height at the beginning and end of the study in each group of zinc supplementation and without zinc supplementation.

The Role of Two Human Milk Oligosaccharides, 2′-Fucosyllactose and Lacto-N-Neotetraose, in Infant Nutrition / 대한소아소화기영양학회지

Human breast milk contains numerous biomolecules. Human milk oligosaccharides (HMOs) are the third most abundant component of breast milk, after lactose and lipids. Amongst the synthetized HMOs, 2′-fucosyllactose (2′-FL) and lacto-N-neotetraose (LNnT) are widely studied and are considered safe for infant nutrition. Several studies have reported the health benefits of HMOs, which include modulation of the intestinal microbiota, anti-adhesive effect against pathogens, modulation of the intestinal epithelial cell response, and development of the immune system. The amount and diversity of HMOs are determined by the genetic background of the mothers (HMO secretors or non-secretors). The non-secretor mothers secrete lower HMOs than secretor mothers. The breastfed infants of secretor mothers gain more health benefit than those of non-secretor mothers. In conclusion, supplementation of infant formula with 2′-FL and LNnT is a promising innovation for infant nutrition.